These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 27260338)

  • 21. Two males with SRY-positive 46,XX testicular disorder of sex development.
    Gunes S; Asci R; Okten G; Atac F; Onat OE; Ogur G; Aydin O; Ozcelik T; Bagci H
    Syst Biol Reprod Med; 2013 Feb; 59(1):42-7. PubMed ID: 23110663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 46 XX, SRY Negative Ovotesticular DSD.
    Kaduskar P; Suryanarayana KM; Babu P; Mysorekar V
    J Assoc Physicians India; 2018 Dec; 66(12):84-85. PubMed ID: 31315334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extended pedigree with multiple cases of XX sex reversal in the absence of SRY and of a mutation at the SOX9 locus.
    Temel SG; Gulten T; Yakut T; Saglam H; Kilic N; Bausch E; Jin WJ; Leipoldt M; Scherer G
    Sex Dev; 2007; 1(1):24-34. PubMed ID: 18391513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Copy number variation in the region harboring SOX9 gene in dogs with testicular/ovotesticular disorder of sex development (78,XX; SRY-negative).
    Marcinkowska-Swojak M; Szczerbal I; Pausch H; Nowacka-Woszuk J; Flisikowski K; Dzimira S; Nizanski W; Payan-Carreira R; Fries R; Kozlowski P; Switonski M
    Sci Rep; 2015 Oct; 5():14696. PubMed ID: 26423656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SRY-negative 46,XX testicular/ovotesticular DSD: Long-term outcomes and early blockade of gonadotropic axis.
    Lambert S; Peycelon M; Samara-Boustani D; Hyon C; Dumeige L; Peuchmaur M; Fiot E; Léger J; Simon D; Paye-Jaouen A; Bouligand J; Siffroi JP; Carel JC; McElreavey K; El Ghoneimi A; Brachet C; Bouvattier C; Martinerie L
    Clin Endocrinol (Oxf); 2021 Apr; 94(4):667-676. PubMed ID: 33296530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 46,XX testicular disorder of sexual development with SRY-negative caused by some unidentified mechanisms: a case report and review of the literature.
    Li TF; Wu QY; Zhang C; Li WW; Zhou Q; Jiang WJ; Cui YX; Xia XY; Shi YC
    BMC Urol; 2014 Dec; 14():104. PubMed ID: 25529318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ovotesticular disorder of sex development with a prostatic gland and review of literature.
    Irkilata HC; Basal S; Taslipinar A; Gur A; Piskin MM; Kurt B; Tahmaz L; Bolu E; Dayanc M
    Andrologia; 2009 Dec; 41(6):387-91. PubMed ID: 19891638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. True hermaphroditism.
    Wang L; Zhu Y; Chen X; Zheng W
    J Int Med Res; 2008; 36(6):1445-6. PubMed ID: 19094457
    [No Abstract]   [Full Text] [Related]  

  • 29. Similar Cause, Different Phenotype: SOX9 Enhancer Duplication in a Family.
    Pinti E; Piko H; Lengyel A; Luczay A; Karcagi V; Fekete G; Haltrich I
    Horm Res Paediatr; 2019; 92(5):335-339. PubMed ID: 31661700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gonadoblastoma and Papillary Tubal Hyperplasia in Ovotesticular Disorder of Sexual Development.
    Şimşek E; Binay Ç; Demiral M; Tokar B; Kabukçuoğlu S; Üstün M
    J Clin Res Pediatr Endocrinol; 2016 Sep; 8(3):351-5. PubMed ID: 27087521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation of mutations in the SRY, SOX9, and DAX1 genes in sex reversal patients from the Sichuan region of China.
    Chen L; Ding XP; Wei X; Li LX
    Genet Mol Res; 2014 Mar; 13(1):1518-26. PubMed ID: 24668626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disorders of Sex Development with Testicular Differentiation in SRY-Negative 46,XX Individuals: Clinical and Genetic Aspects.
    Grinspon RP; Rey RA
    Sex Dev; 2016; 10(1):1-11. PubMed ID: 27055195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Testis development in the absence of SRY: chromosomal rearrangements at SOX9 and SOX3.
    Vetro A; Dehghani MR; Kraoua L; Giorda R; Beri S; Cardarelli L; Merico M; Manolakos E; Parada-Bustamante A; Castro A; Radi O; Camerino G; Brusco A; Sabaghian M; Sofocleous C; Forzano F; Palumbo P; Palumbo O; Calvano S; Zelante L; Grammatico P; Giglio S; Basly M; Chaabouni M; Carella M; Russo G; Bonaglia MC; Zuffardi O
    Eur J Hum Genet; 2015 Aug; 23(8):1025-32. PubMed ID: 25351776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The smallest dislocated microduplication of Xq27.1 harboring
    Oroz M; Vičić A; Požgaj Šepec M; Karnaš H; Stipančić G; Stipoljev F
    J Pediatr Endocrinol Metab; 2023 Jan; 36(1):86-90. PubMed ID: 36189645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coexistence of Trisomy 13 and SRY (-) XX Ovotesticular Disorder of Sex Development.
    Ürel Demir G; Doğan ÖA; Şimşek Kiper PÖ; Utine GE; Boduroğlu K; Gucer S; Alikaşifoğlu M
    Fetal Pediatr Pathol; 2017 Dec; 36(6):445-451. PubMed ID: 29220612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Partial deletion of DMRT1 causes 46,XY ovotesticular disorder of sexual development.
    Ledig S; Hiort O; Wünsch L; Wieacker P
    Eur J Endocrinol; 2012 Jul; 167(1):119-24. PubMed ID: 22573722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The 46, XX Ovotesticular Disorder of Sex Development With Xq27.1q27.2 Duplication Involving the
    Zhuang J; Chen C; Li J; Jiang Y; Wang J; Wang Y; Zeng S; Lin Y; Xie Y
    Front Pediatr; 2021; 9():682846. PubMed ID: 34178900
    [No Abstract]   [Full Text] [Related]  

  • 38. Sex Reversal Syndrome (SRS): A Case of SRY-Positive 46,XX Testicular Disorder.
    Shil K; Ferdousi T; Haq T; Hasanat MA
    J ASEAN Fed Endocr Soc; 2023; 38(2):141-144. PubMed ID: 38045677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Testis formation in XX individuals resulting from novel pathogenic variants in Wilms' tumor 1 (
    Eozenou C; Gonen N; Touzon MS; Jorgensen A; Yatsenko SA; Fusee L; Kamel AK; Gellen B; Guercio G; Singh P; Witchel S; Berman AJ; Mainpal R; Totonchi M; Mohseni Meybodi A; Askari M; Merel-Chali T; Bignon-Topalovic J; Migale R; Costanzo M; Marino R; Ramirez P; Perez Garrido N; Berensztein E; Mekkawy MK; Schimenti JC; Bertalan R; Mazen I; McElreavey K; Belgorosky A; Lovell-Badge R; Rajkovic A; Bashamboo A
    Proc Natl Acad Sci U S A; 2020 Jun; 117(24):13680-13688. PubMed ID: 32493750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pure non-gestational ovarian choriocarcinoma in a 45,XO/46,XX SRY-negative true hermaphrodite.
    Hu T; Yang M; Zhu H; Shi G; Wang H
    J Obstet Gynaecol Res; 2011 Dec; 37(12):1900-5. PubMed ID: 22070612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.